Thank you, Leslie. Good afternoon. Revenue for the third quarter of 2015 was $18.4 million compared with $21.0 million in the second quarter of 2015. This is below our expectation of $19.5 million to $20.5 million and the shortfall was largely in our raw materials business which dropped from Q2 by over $1.3 million. As Morris will describe in a moment, our gross margins were stronger than Q2 and the shortfall did not ripple to the bottom line. In the third quarter of 2015, revenue from North America was 10%, Asia Pacific 66% and Europe 24%. In the third quarter we had two customers that generated more than 10% of revenue and the top five customers generated about 45% of total revenue, reflecting again our diversification of both products and customers. Gross margin in the third quarter increased to 25.1% from 20.9% for the second quarter of 2015 as a result of favorable product mix. Total operating expenses in the third quarter were $5.3 million compared with $5.2 million in the prior quarter. Total stock comp expense was $311,000 of which $5,000 was included in cost of revenues, $260,000 in SG&A, and $46,000 in R&D. The operating loss for the third quarter of 2015 was $711,000 compared with $780,000 operating loss in the previous quarter. Other income for the third quarter was $753,000. This net number consist of four categories; foreign exchange gain of $359,000, equity earnings of our unconsolidated joint ventures of 167,000 gain, net interest earnings on our $45 million in the bank of 102,000, and other items that add up to about $125,000. For Q3 of 2015, we are pleased to show a profit of $42,000 which compares with a net loss of Q2 of $3,000. Accounts receivable net of reserves were $17.1 million at September 30, 2015, compared with $19.3 million at June 30, 2015. Net inventory decreased in the quarter and ended at $38.1 million compared with $38.9 million at June 30. Ending inventory consisted of approximately 53% in raw materials, 40% in work in progress, and 7% in finished goods. This is very close to the spread in Q2 as well. Depreciation and amortization in the third quarter was $1.4 million, and CapEx was coincidently also $1.4 million. We also used cash in Q3 to repurchase our stock, and this amount of cash used was $733,000. Through the end of Q3 we have now spent approximately $2.3 million this and have repurchased a total of 891,000 shares. Cash and cash equivalents with maturities of less than three months, short-term investments and other investments in high grade debt securities was $45.4 million as of September 30, 2015 compared with $46.3 million at the end of June 30, 2015. This concludes the financial review, I will now turn it over to Dr. Morris Young for a review of our business.